Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Fortschritte Der Neurologie-Psychiatrie
|
June 29, 2002
[Current use of ECT in the treatment of depressive disorders]
D Klecha, M Legler, M Hüll
Zeitschrift Fur Gerontologie Und Geriatrie
|
May 1, 1995
[Pathogenetic factors of Alzheimer disease]
J Bauer, M Hüll, M Berger
Current Medicinal Chemistry
|
February 28, 2002
Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs
M Hüll, K Lieb, B L Fiebich
Der Nervenarzt
|
September 6, 2017
[Multiprofessional outpatient psychosocial treatment for elderly patients with mental disorders]
L P Hölzel, M Härter, M Hüll
Expert Opinion on Investigational Drugs
|
November 4, 2000
Anti-inflammatory drugs: a hope for Alzheimer's disease?
M Hüll, K Lieb, B L Fiebich
Neurochemistry International
|
July 6, 2004
Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum
H Slawik, B Volk, B Fiebich, et al.
Der Nervenarzt
|
September 14, 2017
[Psychotherapeutic approaches for treatment of the elderly]
M Hautzinger, P Dykierek, A Fellgiebel, et al.
Annals of the New York Academy of Sciences
|
January 17, 1996
Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques
M Hüll, M Berger, B Volk, et al.
Journal of Neurochemistry
|
October 18, 2000
Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB
B L Fiebich, B Mueksch, M Boehringer, et al.
Neuroscience Letters
|
March 19, 1999
Glutamate but not interleukin-6 influences the phosphorylation of tau in primary rat hippocampal neurons
M Hüll, J Eistetter, B L Fiebich, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Fortschritte Der Neurologie-Psychiatrie
|
June 29, 2002
[Current use of ECT in the treatment of depressive disorders]
D Klecha, M Legler, M Hüll
Zeitschrift Fur Gerontologie Und Geriatrie
|
May 1, 1995
[Pathogenetic factors of Alzheimer disease]
J Bauer, M Hüll, M Berger
Current Medicinal Chemistry
|
February 28, 2002
Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs
M Hüll, K Lieb, B L Fiebich
Der Nervenarzt
|
September 6, 2017
[Multiprofessional outpatient psychosocial treatment for elderly patients with mental disorders]
L P Hölzel, M Härter, M Hüll
Expert Opinion on Investigational Drugs
|
November 4, 2000
Anti-inflammatory drugs: a hope for Alzheimer's disease?
M Hüll, K Lieb, B L Fiebich
Neurochemistry International
|
July 6, 2004
Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum
H Slawik, B Volk, B Fiebich, et al.
Der Nervenarzt
|
September 14, 2017
[Psychotherapeutic approaches for treatment of the elderly]
M Hautzinger, P Dykierek, A Fellgiebel, et al.
Annals of the New York Academy of Sciences
|
January 17, 1996
Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques
M Hüll, M Berger, B Volk, et al.
Journal of Neurochemistry
|
October 18, 2000
Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB
B L Fiebich, B Mueksch, M Boehringer, et al.
Neuroscience Letters
|
March 19, 1999
Glutamate but not interleukin-6 influences the phosphorylation of tau in primary rat hippocampal neurons
M Hüll, J Eistetter, B L Fiebich, et al.
Page
of 5